CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $580.53 | $139K | 328,083 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $581.53 | $186K | 327,763 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $582.79 | $186K | 327,443 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $584.67 | $70K | 327,323 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −330 | $585.58 | $193K | 326,993 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −310 | $586.95 | $182K | 326,683 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $588.02 | $24K | 326,643 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $589.69 | $47K | 326,563 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $591.54 | $95K | 326,403 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 81,410 | ||
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −526 | $593.90 | $312K | 52,946 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,174 | $594.56 | $698K | 51,772 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,256 | $596.07 | $749K | 50,516 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −78 | $596.77 | $47K | 50,438 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −683 | $598.68 | $409K | 49,755 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,010 | $599.38 | $605K | 48,745 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,039 | $600.82 | $1.2M | 46,706 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −401 | $601.25 | $241K | 46,305 |
| 2026-11-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,133 | $602.72 | $683K | 45,172 |
Page 6 of 64 · 1,267 trades